What is benign prostatic hyperplasia?

Benign prostatic hyperplasia (BPH) is a common condition that affects many men worldwide. It is characterised by the enlargement of the prostate gland, which can cause urinary problems such as frequent urination, difficulty starting and stopping urination, and weak urine flow.

What is prostate enucleation plasma?

One of the treatment options for BPH is prostate enucleation plasma. This procedure involves the use of plasma energy to remove the prostate tissue that is causing the urinary problems. The procedure is minimally invasive and has been shown to be effective in treating BPH.

How effective is prostate enucleation plasma?

A recent study published in the Frontiers in Surgery journal evaluated the outcome of immediate transurethral plasma kinetic enucleation of the prostate gland (i-TUPKEP) for the treatment of BPH-associated massive haemorrhage. The study found that i-TUPKEP is a feasible method for controlling BHM and relieving BPH symptoms.

Another study published in the Minoufia Medical Journal evaluated the role of bipolar plasma enucleation of the prostate in the treatment of BPH4. The study found that the procedure is safe and effective in treating BPH and has a low rate of complications.

What other treatment options are available for BPH?

In addition to plasma enucleation, there are other treatment options available for BPH, including medication and surgery. Medications such as alpha-blockers and 5-alpha-reductase inhibitors can help to relieve the symptoms of BPH. Surgery may be recommended for more severe cases of BPH. Minimally invasive procedures like Urolift, Rezum and green light laser are all also an option.